Position in SGMT
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$506,825
-$67,415 QoQ
Shares Held
97,000
0.0% QoQ
Ownership
0.157%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 40%
Shared 0%
None 60%
Common Shares in SGMT Over Time
Shares Held
Position Value (USD)
Derivatives in SGMT
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$473,600
PutShares
80,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026RB Capital Management, LLC holds $581,375 across 2 Biotechnology names. SGMT ranks #1 (87.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SGMT |
Sagimet Biosciences Inc.
This page
|
97,000 | $506,825 | |
| 2 | BDTX |
Black Diamond Therapeutics, Inc.
|
35,000 | $74,550 |
All Filings in SGMT
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $506,825 | 97,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $473,600 | 80,000 | Put | Sole | 2026-02-03 | |
| 2025-12-31 | $574,240 | 97,000 | Shares | Sole | 2026-02-03 | |
| No filing history on record for this holder in this stock. | ||||||